Welcome to Seer first quarter 2025 earnings conference call. At this time all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session.

In this interview, Siddiqui discusses how Seer’s Proteograph™ Product Suite is expanding ... One key challenge is the vast dynamic range of protein concentrations in plasma, which can obscure the ...

The abstract, titled "Clinical and biological implications of plasma proteomic patterns in ... us closer to realizing the full potential of proteomics in oncology." ...

We started Seer with the vision to change the arc of proteomics by providing unprecedented ... which extended the power of Proteograph XT beyond plasma and tissue analysis. We've been very pleased ...